Stock Events

Stock Events

Verisante Technology 

$0.010000
2
+$0.01+733.33%Wednesday 18:11

Statistics

Day High
0.003
Day Low
0.003
52W High
0.013
52W Low
0.0002
Volume
25,860
Avg. Volume
58
Mkt Cap
439,380
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

Nov 29Expected
Q3 2015
Q1 2016
Q2 2016
Q3 2016
Q1 2017
Q2 2017
Q3 2017
-0.01
-0
-0
0
Expected EPS
N/A
Actual EPS
-0.0019

Financials

-Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
0Revenue
23,435.55Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap152.62B
Intuitive Surgical produces advanced robotic-assisted surgical systems, competing in the high-tech medical device market similar to Verisante's cancer detection technology.
Medtronic
MDT
Mkt Cap123.49B
Medtronic offers medical technologies, services, and solutions, including cancer management, which competes with Verisante's cancer detection technologies.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific Corporation provides medical solutions that improve health conditions, including cancer, competing in the same market as Verisante.
Stryker
SYK
Mkt Cap111.95B
Stryker Corporation specializes in medical technologies, including surgical equipment and cancer treatments, competing with Verisante's technology in the oncology sector.
Globus Medical
GMED
Mkt Cap10.48B
Globus Medical develops musculoskeletal solutions but is expanding into technologies that could compete in the broader medical device market, including cancer detection.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories offers a broad range of healthcare solutions including medical devices and diagnostics, potentially competing with Verisante's cancer detection technologies.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson produces a variety of healthcare products, including medical devices and pharmaceuticals that address oncological diseases, similar to Verisante's market.
Baxter International
BAX
Mkt Cap11.9B
Baxter International Inc. provides a portfolio of healthcare products, including hospital and surgical products, which could compete with Verisante's medical device offerings.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet Holdings specializes in musculoskeletal healthcare but has interests in surgical products that could overlap with Verisante's cancer diagnostic technologies.

About

Verisante Technology Inc. presently lacks substantial business operations. Historically, the company focused on developing and manufacturing advanced diagnostic devices for cancer. Originally founded as T-Ray Science Inc., it adopted its current name, Verisante Technology Inc., in January 2011. The firm was established in 2006 and is headquartered in Vancouver, Canada.
Show More
CEO
Thomas A. Braun
Employees
18
Country
Canada
ISIN
CA92346G2036

Listings

OTC Link
US
VRSEF
V
CA
VER-H.V

0 Comments

Share your thoughts

FAQs

What is Verisante Technology stock price today?▼
The current price of VRSEF is $0.01 USD — it has increased by +733.33% in the past 24 hours. Watch Verisante Technology stock price performance more closely on the chart.
What is Verisante Technology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Verisante Technology stocks are traded under the ticker VRSEF.
Is Verisante Technology stock price growing?▼
VRSEF stock has risen by +0% compared to the previous week, the month change is a +733.33% rise, over the last year Verisante Technology has showed a +354.55% increase.
What is Verisante Technology market cap?▼
Today Verisante Technology has the market capitalization of 439,380
What were Verisante Technology earnings last quarter?▼
VRSEF earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Verisante Technology revenue for the last year?▼
Verisante Technology revenue for the last year amounts to 0 USD.
What is Verisante Technology net income for the last year?▼
VRSEF net income for the last year is 23,435.55 USD.
How many employees does Verisante Technology have?▼
As of November 3, 2026, the company has 18 employees.
In which sector is Verisante Technology located?▼
Verisante Technology operates in the Health & Wellness sector.
When did Verisante Technology complete a stock split?▼
The last stock split for Verisante Technology was on June 23, 2022 with a ratio of 1:10.
Where is Verisante Technology headquartered?▼
Verisante Technology is headquartered in Vancouver, Canada.